In a recent published report, Kenneth Research has updated the market report for Immortalized Cell Line Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Immortalized Cell Line Market products.
Immortalized cell lines are either tumorous cells that do not stop dividing or cells that have been artificially manipulated to proliferate indefinitely and can, thus, be cultured over several generations. HepaRG and Hep G2 cell lines are most frequently used for toxicity studies among the currently available human hepatic cell lines.The immortalized cell line plays a vital role in cell biology while studying multicellular organisms and their biochemistry. The demand for immortalized cell lines is increasing and so as the applications. The increasing adoption of immortalized cell lines in stem cell therapy drives the growth of the market.Besides, the increasing awareness regarding the use of cell lines in healthcare, rising vaccines production, increasing application of cell lines in cancer therapy, and use of innovative technology for cell lines have fueled the growth of the market. On the other hand, the high cost of equipment and difficulties in developing a stable and authentic strain have restrained the growth of the immortalized cell line market.
Download Sample of This Strategic Report:- https://www.kennethresearch.com/sample-request-10042898
Moreover, continuous cell lines are widely used by numerous pharmaceutical and biotech-based companies as a specimen for testing the drug efficacy. Due to this, there is a reduction in the use of gnotobiotic animals such as mice, rabbits, and monkeys, among others. Moreover, as these cell lines have a long shelf life and can be easily preserved via cryopreservation and lyophilization techniques, several biotech and pharmaceutical companies are preferring them over other media cultures for performing their R&D activities.
For instance, as per a report published by the Department of Pharmaceutical Sciences and Bio Manufacturing Research Institute and Technology Enterprises (BRITE), in 2014, around 1.3 USD billion capital was invested in new pharmaceuticals for drug discovery through cell line culture.
The global immortalized cell line market is segmented based on method, application, and end-user.
Based on method, the market is further segmented into virus induction, HTERT expression, inactivation of tumor, suppression genes, and others. Based on application, the market is segmented into diagnostics, drug discovery, vaccine production, tissue engineering and regenerative medicine, and others.Based on end-user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, and research laboratories.The global immortalized cell line market was valued at USD 2,421.34 million in 2017 and is expected to register a CAGR of 9.30% during the forecast period from 2018 to 2023.
Lonza Group AG, Corning Incorporated, Thermo Fisher Scientific, Selexis SA, Valneva, European Collection of Authenticated Cell Cultures (ECACC), Sartorius AG, ATCC (American Type Culture Collection Inc.), Merck KGaA, and Wuxi App Tec, and others
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global immortalized cell line market
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global immortalized cell line market
• To provide a detailed analysis of the value chain and supply chain of the global immortalized cell line market
Request For full report-https://www.kennethresearch.com/sample-request-10042898
• Pharmaceutical Companies
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors
• The global immortalized cell line market is expected to reach USD 4,105.62 million by 2023 at a CAGR of 9.30% from 2018 to 2023
• On the basis of method, virus induction accounted for the largest market share of 39.9% in the year 2017 and was valued at USD 965.97 million in the same year
• On the basis of application, diagnostic accounted for the largest market share of 32.1% in 2017
• The Americas holds the largest share of the global immortalized cell line market which is expected to reach USD 1,505.38 million by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 10.04 % from 2018 to 2023
o North America
o South America
o Rest of Europe
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Name: Kenneth research
Phone: +1 313 462 0609